Enhanced diagnosis of severe bacterial and fungal respiratory infection in children using a rapid syndromic

John Alexander Clark1,2, Theodore Gouliouris2,3, Andrew Conway Morris2,4,5

  • 1Department of Paediatrics, Addenbrooke's Hospital, Cambridge Biomedical Campus, Cambridge, UK.

PubMed
Abstract

Insights

Molecular diagnostic arrays rapidly identify bacterial and fungal pathogens in critically ill children with respiratory infections. These advanced tests aid early, specific diagnoses in the pediatric intensive care unit (PICU).

Area of Science:

  • Microbiology
  • Molecular Diagnostics
  • Pediatric Critical Care

Background:

  • Identifying the microbiological cause of severe respiratory infections in critically ill children is challenging.
  • Molecular diagnostic arrays offer a promising alternative for pathogen detection.
  • Understanding clinician interpretation of these array results for decision-making is limited.

Observation:

  • A custom 52-respiratory pathogen TaqMan array card (TAC) was used to diagnose three cases of bacterial and fungal lower respiratory tract infection (LRTI) in a pediatric intensive care unit (PICU).
  • Early diagnosis of *Candida albicans* pneumonia in a ventilated trauma patient was supported by TAC, preceding culture results.
  • A rare case of psittacosis and *Haemophilus influenzae* pneumonia were also identified, with diagnoses faster than conventional methods.

Findings:

  • The custom TAC enabled diagnoses not achievable with commercially available arrays.
  • Pathogen-specific diagnoses were established more rapidly compared to routine microbiological cultures.
  • Two of the three cases involved rare pathogens or atypical presentations.

Implications:

  • The selection of pathogens on molecular arrays and multidisciplinary interpretation are key for effective PICU diagnostics.
  • Molecular arrays hold significant potential for improving early, pathogen-specific diagnosis of LRTI in the PICU.
  • These findings support the broader integration of molecular diagnostics in pediatric critical care settings.

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Rapid Identification of Pathogens01:25

Rapid Identification of Pathogens

MALDI-TOF MS has transformed clinical microbiology by offering a rapid and reliable method for pathogen identification. The traditional approach to microbial identification typically involves time-consuming culture techniques and biochemical tests, which can delay the initiation of appropriate antimicrobial therapy. MALDI-TOF MS avoids these delays by using characteristic ribosomal protein mass patterns of microbial cells, enabling accurate species-level identification within minutes.Principle...
Automated Microbial Diagnostics01:24

Automated Microbial Diagnostics

Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.Microbial Identification with ID CardsThe...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...